Financials Thai NVDR Co., Ltd.

Equities

KLINIQ

THB058010000

Healthcare Facilities & Services

End-of-day quote Thailand S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
40.75 ^THB	0.00%		-4.12%	-2.98%

24/05	Consortium of buyers agreed to acquire 5% stake in The Klinique Medical Clinic Public Company Limited from Ekachai Medical Care Public Company Limited for THB 430 million.	CI
14/05	The Klinique Medical Clinic Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Valuation

Fiscal Period: December	2022	2023	2024	2025
Capitalization ¹	8,525	9,240	8,965	-
Enterprise Value (EV) ¹	8,525	9,240	8,965	8,965
P/E ratio	32 x	32.1 x	24.5 x	19.7 x
Yield	-	3.1%	3.26%	3.56%
Capitalization / Revenue	-	4.04 x	2.94 x	2.32 x
EV / Revenue	-	4.04 x	2.94 x	2.32 x
EV / EBITDA	-	17.1 x	12.9 x	10.3 x
EV / FCF	-	22.1 x	31.7 x	13.5 x
FCF Yield	-	4.53%	3.16%	7.38%
Price to Book	-	5.43 x	4.71 x	4.4 x
Nbr of stocks (in thousands)	2,20,000	2,20,000	2,20,000	-
Reference price ²	38.75	42.00	40.75	40.75
Announcement Date	28/02/23	28/02/24	-	-

¹THB in Million²THB

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2022	2023	2024	2025
Net sales ¹	-	2,285	3,046	3,868
EBITDA ¹	-	539.8	695	867
EBIT ¹	-	345.2	452	550
Operating Margin	-	15.11%	14.84%	14.22%
Earnings before Tax (EBT) ¹	-	350.2	457	553
Net income ¹	205.5	288.6	365	456
Net margin	-	12.63%	11.98%	11.79%
EPS ²	1.210	1.310	1.660	2.070
Free Cash Flow ¹	-	418.6	283	662
FCF margin	-	18.32%	9.29%	17.11%
FCF Conversion (EBITDA)	-	77.55%	40.72%	76.36%
FCF Conversion (Net income)	-	145.03%	77.53%	145.18%
Dividend per Share ²	-	1.300	1.330	1.450
Announcement Date	28/02/23	28/02/24	-	-

¹THB in Million²THB

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2024 Q1
Net sales ¹	687.9
EBITDA	-
EBIT	-
Operating Margin	-
Earnings before Tax (EBT)	-
Net income ¹	75.27
Net margin	10.94%
EPS	-
Dividend per Share	-
Announcement Date	14/05/24

¹THB in Million

Estimates

Balance Sheet Analysis

Fiscal Period: December	2022	2023	2024	2025
Net Debt	-	-	-	-
Net Cash position	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-
Free Cash Flow ¹	-	419	283	662
ROE (net income / shareholders' equity)	-	17.2%	20%	23%
ROA (Net income/ Total Assets)	-	10.6%	12%	12%
Assets ¹	-	2,718	3,042	3,800
Book Value Per Share ²	-	7.740	8.650	9.270
Cash Flow per Share	-	-	-	-
Capex ¹	-	367	403	343
Capex / Sales	-	16.04%	13.23%	8.87%
Announcement Date	28/02/23	28/02/24	-	-

¹THB in Million²THB

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Thai NVDR Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

40.75 THB

Average target price

46.5 THB

Spread / Average Target

+14.11%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
THAI NVDR CO., LTD.	-2.98%	244M
AIER EYE HOSPITAL GROUP CO., LTD.	-25.47%	15.13B
BANGKOK DUSIT MEDICAL SERVICES	-1.80%	11.77B
IHH HEALTHCARE	+3.48%	11.71B
APOLLO HOSPITALS ENTERPRISE LIMITED	+5.44%	10.36B
ENCOMPASS HEALTH CORPORATION	+27.17%	8.54B
RAMSAY HEALTH CARE LIMITED	-6.29%	7.42B
THE ENSIGN GROUP, INC.	+6.08%	6.72B
MOUWASAT MEDICAL SERVICES COMPANY	+0.89%	6.02B
DALLAH HEALTHCARE COMPANY	-4.31%	4.28B

Hospitals, Clinics & Primary Care Services